Privia Health Group (PRVA) Stock: Buy, Sell, or Hold?
PRVA - Privia Health Group, Inc. Common Stock
$20.37
0.00 (0.00%)
▲
5d:
-1.45%
30d:
-5.43%
90d:
-12.8%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When PRVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PRVA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PRVA shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.30
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$25.02
18.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRVA is currently trading at $20.37, which is considered oversold relative to its 30-day fair value range of $20.52 to $22.49. The stock's valuation (Forward PE: 19.2) is in line with its historical norms (21.0). Remarkably, the market is currently pricing in an annual earnings decline of 3.0% over the next few years. This pessimistic expectation contrasts with the company's recent 250.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PRVA is in a downtrend. The price is currently testing key support at $20.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PRVA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.67 (+55.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRVA is in a downtrend. The price is currently testing key support at $20.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PRVA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.67 (+55.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.52 -
$22.49
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding PRVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 55.5% below Wall St target ($31.67)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$20.52 -
$22.49
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$20.17
Resistance Level
$21.43
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.16
Wall Street Target
$31.67
(+55.5%)
Revenue Growth (YoY)
21.4%
Earnings Growth (YoY)
250.0%
Profit Margin
1.2%
Valuation Discount vs History
-3.0% cheaper
PE vs Historical
19.2 vs 21.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.0%
(market-implied from PE analysis)
1-Year Target
$19.76
(-3%)
2-Year Target
$19.17
(-6%)
3-Year Target
$18.59
(-9%)
3-Yr Target (if PE normalizes)
(PE: 19→21)
$20.38
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 21.4%)
$38.40
(+89%)
Base:
(SPY PE: 19.2, Growth: 21.4%)
$36.46
(+79%)
Bear:
(PE: 16.3, Growth: 21.4%)
$30.99
(+52%)
📈
Valuation based on Current Earnings
Forward PE: 18.80 | Forward EPS (Implied): $1.08
Bull Case
$24.60
(+21%)
Analyst growth 15.0%, PE expands to 19.7
Base Case
$20.37
(0%)
Market implied 0.0%, PE stable at 18.8
Bear Case
$15.58
(-24%)
Severe decline -15.0%, PE contracts to 16.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.2 to 21.0
Stabilization Target:
$22.33
(+9.6%)
PE Expansion Potential:
+9.6%
Share & Embed Analysis
Last updated: September 11, 2026 2:28 PM ET
Data refreshes hourly during market hours. Next update: 3:28 PM
Data refreshes hourly during market hours. Next update: 3:28 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
David Mountcastle
SELL
5566 shares
2026-04-02
David Mountcastle
SELL
6391 shares
2026-03-16
Parth Mehrotra
SELL
26509 shares
2026-03-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$294 | 39 SELL |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 49 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$33 | 45 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 47 HOLD |
Advanced PRVA Option Strategies
Professional options setups generated by AI based on today's PRVA price and gamma walls.
